Immuneering
+$0.44 (+11.31%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuneering and other ETFs, options, and stocks.
About IMRX
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.
CEO
Benjamin J. Zeskind
Employees
64
Headquarters
Cambridge, Massachusetts
Founded
2008
IMRX Key Statistics
Market cap
114.25M
Price-Earnings ratio
—
Dividend yield
—
Average volume
83.46K
High today
$4.50
Low today
$3.75
Open price
$3.92
Volume
113.86K
52 Week high
$33.99
52 Week low
$3.74
Analyst ratings
83%
of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%
IMRX Earnings
-$1.61
-$1.07
-$0.54
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Sep 8, Pre-Market